Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy.
about
Integrating cryptococcal antigen screening and pre-emptive treatment into routine HIV carePoint of Care Testing for the Diagnosis of Fungal Infections: Are We There Yet?Preventing Cryptococcosis-Shifting the Paradigm in the Era of Highly Active Antiretroviral TherapyA screen-and-treat strategy targeting visceral leishmaniasis in HIV-infected individuals in endemic East African countries: the way forward?Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.Factors impacting early mortality in tuberculosis/HIV patients: differences between subjects naïve to and previously started on HAART.Antigen-specific interferon-gamma responses and innate cytokine balance in TB-IRISIncidence and predictors of tuberculosis among adult people living with human immunodeficiency virus at the University of Gondar Referral Hospital, Northwest Ethiopia.Predictors of mortality among TB-HIV Co-infected patients being treated for tuberculosis in Northwest Ethiopia: a retrospective cohort study.LPS-binding protein and IL-6 mark paradoxical tuberculosis immune reconstitution inflammatory syndrome in HIV patients.Incidence of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome and impact on patient outcomeTuberculosis of the central nervous system in immunocompromised patients: HIV infection and solid organ transplant recipientsThe complex relationship between human immunodeficiency virus infection and death in adults being treated for tuberculosis in Cape Town, South AfricaLower Pre-Treatment T Cell Activation in Early- and Late-Onset Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.Characteristics and treatment outcomes of tuberculosis retreatment cases in three regional hospitals, Uganda.Time to HAART Initiation after Diagnosis and Treatment of Opportunistic Infections in Patients with AIDS in Latin AmericaRisk factors for mortality among malnourished HIV-infected adults eligible for antiretroviral therapy.Added Value of Long-Term Cytokine Release Assays to Detect Mycobacterium tuberculosis Infection in HIV-Infected Subjects in Uganda.Early immunologic failure is associated with early mortality among advanced HIV-infected adults initiating antiretroviral therapy with active tuberculosisReducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa.Predictors of Mortality among Tuberculosis/HIV-Coinfected Persons in Southwest Ethiopia: A Case-Control Study.Effectiveness and safety of concurrent use of first-line antiretroviral and antituberculous drugs in rwanda.Pharmacogenomic implications of the evolutionary history of infectious diseases in AfricaInterventions to reduce mortality in sub-Saharan Africa among HIV-infected adults not yet on antiretroviral therapy.The cryptococcal antigen lateral flow assay: A point-of-care diagnostic at an opportune time.Inadequate monitoring in advanced stages of disease with lack of supportive counseling increases attrition among patients on antiretroviral treatment at a large urban clinic in Uganda.Bedaquiline versus placebo for management of multidrug-resistant tuberculosis: A systematic review.Cryptococcal antigen screening by lay cadres using a rapid test at the point of care: A feasibility study in rural Lesotho.Predictors of mortality in adults on treatment for human immunodeficiency virus-associated tuberculosis in Botswana: A retrospective cohort study.Opportunistic diseases diminish the clinical benefit of immediate antiretroviral therapy in HIV-tuberculosis co-infected adults with low CD4+ cell countsPredictors and short-term outcomes of recurrent pulmonary tuberculosis, Uganda: a cohort study
P2860
Q24610933-46A2E7FB-1B6E-4618-9EB9-61AFC6110B6BQ26746020-A7614548-D032-422A-B54A-39E929DA88B5Q26994750-EBDE3768-73BA-4B14-B74A-BA5D3C8C8E83Q28541690-EA51C3E9-13E7-434E-A7ED-E6F38EA89996Q34024416-50E74998-4956-4F6D-93F0-53DDFD118075Q34438327-49B02080-413E-420E-A4FA-1F5496A80A43Q34557159-E80E9130-B41C-4AA3-A35C-8B25B8643B13Q34785986-7C579CE0-5DAD-4C86-8B9A-3129150D61CEQ34787863-1BCF0509-8C5F-4B9C-ACFE-7A133AC47629Q35060755-52208C3F-17F2-43BA-A8D7-1918453AE17FQ35075811-81370B9E-DC37-443F-BB84-361EB4AAB75BQ35557036-0E816FD5-AAFE-49AF-9031-10EDFDC3D031Q35665530-A5C85A16-5C1D-47B1-8B08-3F990CDFA3F3Q35711609-CF7D52E0-7AFA-430B-B746-AEF16D1326ADQ35719180-7A35A04B-C347-4045-89F2-67C5171DAD23Q36043414-8938CF27-1DC9-4241-81B3-7DDAC4A24BDCQ36161797-A2BF6C44-5F74-4F23-85DB-6FC5D0248DA9Q37025889-BB6B2FC8-EBEE-4856-924D-F2427DA08428Q37272336-43246499-BDE3-41A6-A484-BF820E9CBB80Q37285167-D7BFF3C1-6065-4676-9C41-336A26BB56DCQ37591303-F565FCF9-6853-4092-A46D-11D8B9D4BF7FQ37593420-C877B849-CE37-4850-8F66-A640345995B1Q37737731-A18655D0-6FEA-42A0-A194-31B587510DBDQ37965693-54678C04-3E30-4A7F-A7E9-1259774995B2Q38328870-E3EBFC58-9720-42B4-9494-5FEE8877D184Q38864481-6C46ACEC-3621-478D-AB90-F0122D579A75Q38984806-5E93878B-74BB-4ABD-9F8E-69A878C057ECQ40055779-ADC5B590-FD37-4809-95C7-87349D2496D8Q53691928-B29B73DA-CD7D-4C18-95E4-615A9D211C12Q56909177-AE5AF0CD-835E-4F6A-AC08-C16F193071ABQ56913911-55A2A3E1-DA21-4330-81B6-2D7EABA85DF9
P2860
Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Incidence and predictors of mo ...... encing antiretroviral therapy.
@en
type
label
Incidence and predictors of mo ...... encing antiretroviral therapy.
@en
prefLabel
Incidence and predictors of mo ...... encing antiretroviral therapy.
@en
P2093
P50
P1476
Incidence and predictors of mo ...... encing antiretroviral therapy.
@en
P2093
Doreen Mazakpwe
Joris Menten
Kenneth Luzinda
Luc Kestens
Marguerite Massinga-Loembe
Peter Reiss
Roy D Mugerwa
TB-IRIS Study Group
William Worodria
P356
10.1097/QAI.0B013E3182255DC2
P407
P577
2011-09-01T00:00:00Z